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Escherichia coli 16 has potential probiotic properties including antimicrobial activity due to 
extracellular secretion of colicins E1/1a1b. Inulosucrase (InuJ) enzyme catalyses the polymerization of 
a fructose moiety of sucrose leading to the formation of fructooligosaccharides. The present 
investigation compared the activity of InuJ enzymes cloned into pMAL-p2ΔlacI
Q
 a deletion vector and 
transformed into E. coli 16 and standard strain that is, E. coli BL21. Specific activities of InuJ enzyme 
were estimated in supernatant, periplasm and lysate. Specific activities of InuJ activity in cell lysate 
were similar in E. coli 16 and E. coli BL21 without induction of  tac promoter with isopropyl thio-β-D-
galactoside (IPTG). InuJ activity is mainly present in the periplasm of E. coli BL21 whereas in E. coli 16, 
most of the activity is in the supernatant. Superantant of E. coli 16 strain also showed good 
antibacterial activity due to colicin E1/Ia1b. Colicin E1/1a1b transport system could allow  extracellular 
secretion of InuJ proteins in probiotic E. coli 16.  
 





Prebiotics are a category of nutraceutical product that 
has the ability to promote the growth of specific beneficial 
gut bacteria (Kelly, 2008). In 2007, Roberfroid defined 
prebiotics as “a selectively fermented ingredient that 
allows specific changes, both in the composition and/or 
activity in the gut microflora that confers health benefit”. 
Fructooligosaccharides (FOS) has been used as prebiotic 
and is considered as a functional food ingredient 
(Cherbut, 2002; Fanaro et al., 2005; Bouhnik et al., 2006; 
Roberfroid, 2007; Paineau et al., 2008).  FOS is the 
common name for fructose oligomers that are mainly 
composed of 1-kestose (GFS2), 2-nystose (GF3) among 
others in which fructose units are bound at the β-2, 1 
position of sucrose through the transfructosylating 
enzymes such as glucosyltransferases, fructosyltrans-
ferases and inulosucrase (Yun et al., 1996). Inulosucrase 
has been previously shown to be involved in the 
synthesis of FOS (Van Hijum et al., 2006). 
Escherichia coli,  a Gram negative bacterium is widely 
used as a host strain for recombinant protein production 
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Table 1. Bacterial strains and plasmids used. 
 




Expression vector, derived from pET15b by insertion  of a inulosucrase  inuj gene; 
Ap
r
 Anwar et al.,2008 
pMAL-p2ΔlaclQ   deletion of lacIQ  from  periplasmic expression vector pMal-p2; Ap
r
 This study 
pMAL-p2ΔlaclQ -
inuJ 
derived  from  periplasmic expression vector pMAL-p2Δlacl
Q






E. coli BL21 F′ ompT hsdSB (rB- mB-) gal dcm 
Sambrook and Russell, 
2001 
E. coli DH5α 
 
F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG Φ80dlacZΔM15Δ(lacZYA-
argF)U169, hsdR17(rK- mK+), λ- 
Sambrook and Russell, 
 2001 




in industry. Some natural E. coli strains secrete protein 
extracellulally but their mechanisms of secretion are not 
clearly understood, nor are they widely exploited for 
recombinant protein production and metabolic 
engineering (Ni and Chen, 2009). In some case, 
recombinant proteins directed to the periplasm were 
found in the medium but the process is not known (Choi 
and Lee, 2004; Mergulhao et al., 2005). Sommer et al. 
(2010) constructed a plasmid which contains bacteriocin 
release proteins (BRP) that allow secretion of 
recombinant protein from the periplasm into the culture 
medium (Sommer et al., 2010).  It was known that BRP 
or lysis proteins are responsible for the release of colicins 
such as A, E1, E2, K, N, U, and Y (Cascales et al., 2007; 
Singh et al., 2012). Previously, we had reported E. coli 16 
isolated from rat fecal matter to possess characteristic 
such as acid tolerance, antibiotic sensitivity, no 
pathogenicity and antimicrobial activity against the 
members of Enterobacteriacae family. Antimicrobial 
activity was due colicin E1/1a 1b which is secreted into 
the culture media in E. coli 16 (Kumar et al., 2009). All 
these above characteristic attributed E. coli 16 to be a 
potential probiotic. In this study, we compared the 
heterologous expression of Inulosucrase from a 




MATERIALS AND METHODS 
 
Bacterial strains, plasmids and growth conditions 
 
All the E. coli strains and plasmids used in this study are listed in 
Table 1. The bacterial strains used in this study were E. coli DH5α, 
E. coli 16 and E. coli BL-21.  Strains of E. coli were grown at 37°C 
in the Luria Bretani medium (Hi-Media Laboratories,Mumbai, India). 
The minimal medium used had the following composition: 12.8 g/l 
Na2HPO4·7H2O, 3 g/l KH2PO4, 0.5 g/l NaCl, 1 g/l NH4Cl, 3 mg/l 
CaCl2, 1 mM MgSO4, thiamine and trace elements. Antibiotics were 
used at the following final concentrations: ampicillin 100 μg ml
-1
. 
Plasmid pET15b-inuJ was a generous gift from Dr. Dijkhuizen. E. 
coli DH5α was used for constructing recombinant plasmids. E. coli 
BL21and E. coli 16 were used for expressing the proteins under in- 
vitro condition.  
 
 







pMAL-p2 was digested with Mlu I/EcoRV, end filled and further self 
ligated, leading to disruption of lacI
Q
 gene to obtain constitutive 
pMAL-p2Δlacl
Q
 vector. Confirmation of disrupted clones of pMAL-
p2Δlacl
Q
 was done on X-gal plate without isopropylthio-β-
galactoside (IPTG). Plasmid pET15b-InuJ, containing inulosucrase 
gene, was digested with NcoI/BamHI to insert the 1.7 kb DNA 
fragment containing the inuJ gene into pMAL-p2Δlacl
Q 
for 
periplasmic expression. The recombinant plasmid was confirmed by 
restriction digestion. All the above DNA manipulations were carried 
out according to the procedures described by Sambrook and 
Russell (2001). Further confirmation of E. coli harbouring 
inulosucrase constructs cells were inoculated in M9 media (Hi-
Media Laboratories, Mumbai, India)  containing 20 mM sucrose as 




















 -InuJ were 




Preparation of E. coli cell extracts and InuJ activity assay 
 





InuJ constructs were grown overnight and harvested by 
“centrifugation (Heraeus Fresco refrigerated centrifuge, Thermo 
Scientific, Germany) at 9,200 g for 2 min at 4°C. The cell pellet was 
washed twice with 50 mM phosphate buffer (pH=7. 0) followed by 
re-suspension in the same buffer. The cells were then subjected to 
sonication (Branson Sonifier Model 450) for a total period of 1 min 
at a pulse rate of 15 s in an ice bath, followed by centrifugation at 
9,200 g at 4°C for 30 min to remove cell debris. The cell free extract 
was used for the inulosucrase assays. Periplasmic fraction (Ames 
et al., 1984) and extracellular fraction were also checked for the 
presence of the enzyme activity. The initial rate of the inulosucrase 
reaction was measured at 37°C in 50 mM potassium phosphate 
buffer (pH 7.0) in the presence of 500 mM sucrose. The enzyme 






Figure 1. Phenotypic confirmation of E. coli16  harbouring pMAL-p2ΔlacI
Q
 plasmid on X-gal without 
addition of IPTG. X-gal breakdown leads to blue colour indicate deletion of  IacI
Q 
where as control 




inulosucrase catalyzes the formation of fructose polymers from 
sucrose in turn liberating glucose and thus this can be used as an 
indicator of the enzyme activity. Glucose was estimated using the 3, 
5- dinitrosalicylic acid (DNSA) method (Miller et al., 1959). 
 
 
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) and native gel activity staining of recombinant 
inulosucrase 
 
SDS PAGE gel was performed as mentioned by Sambrook and 
Russell (2001) to detect inulosucrase polypeptide. Samples were 
mixed with an equal amount of 2X sample buffer (0.125 M Tris-HCl 
[pH 6.8], 1% SDS, 20% glycerol, and incubated at 90°C for 5 min, 
centrifuged at 10,000 rpm for 20 s, and loaded onto a 12% slab gel. 
After electrophoresis, the gel was stained with Coomassie blue. 
Native gels were incubated at ambient temperature in McIllvaine’s 
buffer (pH 7.0) with 10% sucrose. Formation of FOS within the gel 
led to white, turbid bands indicating the position of active enzyme. 
Prolonged incubation caused bursting of the gel due to excessive 





Statistical evaluation of the data was done by one-way analysis of 
variance (ANOVA) followed by Bonferroni’s multiple comparison 
test and the results were expressed as mean ± SEM using Graph 
Pad Prism version 3.0 for Windows, Graph Pad Software, San 





Molecular and phenotypic confirmation of E. coli 
transformants of pMAL-p2∆lacI
Q





Deletion of repressor binding protein from pMAL-p2 
plasmid gave rise to “constitutive phenotype” (Figure 1). 
The deleted plasmid clones and the original plasmid 
clones were plated on X-gal plates without IPTG. It was 
found that the deletion clone cleave X-gal showed blue 
colonies while the plasmid control does not cleave X-gal 
showed white colonies. Deletion of repressor binding 
protein in pMAL-p2 to form pMAL-p2ΔlacI
Q
 vector and 
insertion of inulosucrase gene in pMAL-p2ΔlacI
Q
 was 
confirmed by the release of 2.3 kb fragments upon 
digestion with SalI and BglII enzymes. Phenotypic 
confirmation of the clones containing the functional 
enzyme indeed grew on sucrose without IPTG while the 
vector controls and wild types did not grow in the 
presence of sucrose (Figure 2). 
 
 
SDS-PAGE and activity of inulosucrase enzymes 
 
The SDS-PAGE of cell free extracts of E. coli BL21 (DE3) 
containing pET-InuJ showed the presence of 63 kD 
protein band where as pMAL-p2ΔlacI
Q
- InuJ band was 
seen at 106 kD (Figure 3). This is because InuJ protein is 
obtained as maltose binding protein (MBP)s-InuJ as a 
translational fusion protein with a molecular weight of 106 
kD.  In native gel loaded with the supernatant of E. coli 16 
harboring pMAL-p2ΔlacI
Q
- InuJ incubated in McIllvaine’s 
buffer (pH 7.0) with 10% sucrose showed clearly a white 
turbid band indicating the activity of inulosucrase 
enzymes (Figure 4). Specific activity of inulosucrase 
enzyme in the supernatant, periplasm and lysate of E. 
coli 16 and BL-21 strain harbouring pMAL-p2∆lacI
Q
-InuJ 
were monitored (Figure 5a, b and c). In lysate the 
inulosucrase activities were similar in both the strains 
harbouring the plasmids. E. coli BL21strain harbouring 
pMAL-p2∆lacI
Q
-inuJ and pET-InuJ activity were found in 
the periplasm. While In E. coli 16 strain the activity was 
mostly found in the supernatant. 






Figure 2.  Growth of inulosucrase transformants in presence of M9 medium containing sucrose as a sole carbon source. 
Lane 1, E. coli BL21 (DE3) containing pET-15b-inuJ with IPTG; Lane 2, E. coli BL21 (DE3) containing pET-15b-inuJ 
without IPTG; Lane 3, E. coli BL21; Lane 4, E. coli 16 containing pMAL-p2ΔlacI
Q
; Lane 5, E. coli 16 containing pMAL-
p2ΔlacI
Q






Figure 3. Protein profiles of E. coli BL21 expressing inulosucrase enzymes, resolved on 10% 
resolving gel by SDS-PAGE.  Lane 1, BSA 66 kd; Lane 2, pMAL-p2 control; Lane 3, pMAL-
p2Δlacl
Q
; Lane 4, pMAL-p2Δlacl
Q
-inuJ 106kd; Lane 5, pMAL-p2Δlacl
Q
; Lane 6, pMAL-p2Δlacl
Q
-
inuJ 106kd; Lane 7, pMAL-p2Δlacl
Q
; Lane 8, pMAL-p2Δlacl
Q







Modernization of diet resulted in a significant increase in 
the amount of  added sugar such as sucrose and 
fructose, in food products leading to its daily consumption 
amounting to ≥ 100 g of sugar per day (Basciano et al., 
2005). Intake of sweetener above 25% of total energy 
consumed will cause hypertriglyceridemia and gastroin-
testinal symptoms (Tappy and Kim-Anne, 2010). High 
amount of sucrose and fructose in diet ultimately leads to 
various metabolic disorder such as obesity, diabetes and 
hypertension  






Figure 4. Native PAGE to show the activity of inulosucrase enzyme in supernatant of E. coli 16. White turbid band 
indicate FOS generation due to the activity of inulosucrase enzymes. Lane 1, pMALp2ΔlacI
Q
-InuJ; Lane 2, 
pMALp2ΔlacI
Q
; Lane 3, pMALp2ΔlacI
Q






among others. Complex sugars like FOS on the other 
hand are beneficial and classified as functional food 
ingredient (Roberfroid, 2007; Kelly, 2008, 2009). FOS are 
also known for its antilipogenic effects  and are useful in 
reducing blood glucose level in humans (Delzenne and 
Kok, 2001).  
Interestingly, FOS can be produced from sucrose by 
the action of enzymes like inulosucrase which break 
down sucrose and polymerize it into FOS. In this case, 
we decided to genetically engineer the previously charac-
terized (Kumar et al., 2009) potential probiotic E. coli 16  
and E. coli BL-21 to express and secrete InuJ without 
induction with IPTG. As under in-vivo condition it is not 
possible to induce the gene by external factors such as 
IPTG. Similarly we cannot also use such promoter which 
constitutively expressed and form inclusion bodies. 
Hence we deleted the repressor protein of pMal-p2, that 
lead to moderate expression of Inulosucrase without 
induction with IPTG. Under in-vivo condition, this 
periplasmic InuJ could now access sucrose in the diet 
and polymerize it into FOS.  
To demonstrate this characteristic we construct the 
plasmid and transformed into the host such as potential 
probiotic E. coli 16  and E. coli BL-21 and measured the 
activity of  InuJ by using the DNSA methods to detect 
free glucose as an indicator of the sucrose hydrolysis 
(Figure 5). We also checked for direct indication of 
polymer synthesis using native gel electrophoresis 
(Figure 4). Surprisingly the heterologous protein even 
though targeted to the periplasm by the expression vector 
found its way into the extracellular medium in the case of 
E. coli 16 but not in E. coli BL-21. Comparisons of 
specific activity of inulosucrase cloned into periplasmic 
expression vector, transformed and expressed in E. coli 
16 and E. coli BL21 demonstrated that extracellular 
expression is achieved only in colicin producing 
microorganism. Various reports suggested that BRP 
protein is responsible for the release of colicin such as 
colicin A, E1, E2, K, N, U, and Y into the extracellular 
medium (Cascales et al., 2007; Sommer et al., 2010; 
Singh et al.,  2012). There are reports that extracellular 
secretion could be achieved in E. coli strain by co-
expression of a  lysis-promoting protein (Sommer et al., 
2010). E. coli cells having the outer membrane generally 
do not help to secrete periplasmic proteins into the 
culture medium.  
Here, we have shown a potential probiotic E. coli 16  
that expresses E1/1a1b Colicin and its transport system 
mediates inulosucrase into the culture medium, that leads 
to the conversion of sucrose into FOS. Extracellular 
secretion of InuJ enzymes is better than the periplasmic 
secretion under in-vivo condition. Engineered E. coli16 
strain produce colicin and FOS thus its give health 
benefits; colicin fight against enteropathogens and FOS a 
prebiotic product activate the beneficial microbes present 
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Figure 5. Specific activity of inulosucrase enzyme in a, Lysate; b, periplasm and c, supernatant of E. 
coli 16  and BL-21 strain containing (pMAL-p2ΔlacIQ-InuJ). All values are expressed as mean ± SD 
(n=4-6) each group and analysis was done using ANOVA. ***p<0.001, **p<0.01 and *p<0.05 compare 
to E. coli 16. 
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